share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

辉瑞 | 4:持股变动声明-高管 BOURLA ALBERT
美股sec公告 ·  04/16 13:55
Moomoo AI 已提取核心信息
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction of the company's stock on April 15, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The action reflects a change in Bourla's investment in the company, but without additional information, the impact on his total holdings remains unclear.
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction of the company's stock on April 15, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The action reflects a change in Bourla's investment in the company, but without additional information, the impact on his total holdings remains unclear.
辉瑞公司(PFE)董事长兼首席执行官阿尔伯特·布拉于2024年4月15日执行了该公司股票的交易。公告中未披露该交易的具体细节,包括股票数量、股票性质、交易价格和股票总价值。该行动反映了Bourla对该公司的投资的变化,但如果没有其他信息,对其总持股的影响尚不清楚。
辉瑞公司(PFE)董事长兼首席执行官阿尔伯特·布拉于2024年4月15日执行了该公司股票的交易。公告中未披露该交易的具体细节,包括股票数量、股票性质、交易价格和股票总价值。该行动反映了Bourla对该公司的投资的变化,但如果没有其他信息,对其总持股的影响尚不清楚。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息